Interferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response

BACKGROUND: Tumour-derived exosomes (TEXs) have a potential for application in cancer vaccines. Whether TEXs after induction by interferon regulatory factor 1 (IRF-1) are capable of enhancing the antitumour response remains to be determined. METHODS: Exosomes released by tumour cells infected with I...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mu-qing, Du, Qiang, Varley, Patrick R, Goswami, Julie, Liang, Zhihai, Wang, Ronghua, Li, Hui, Stolz, Donna B, Geller, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765230/
https://www.ncbi.nlm.nih.gov/pubmed/29112686
http://dx.doi.org/10.1038/bjc.2017.389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765230/
https://www.ncbi.nlm.nih.gov/pubmed/29112686
http://dx.doi.org/10.1038/bjc.2017.389

Ejemplares similares